Interleukin-10 inhibits gram-negative-microbe-specific human receptor activator of NF-κB ligand-positive CD4+-Th1-cell-associated alveolar bone loss in vivo

Infection and Immunity

Volumn 74, Issue 8, 2006, Pages 4927-4931

  Zhang, Xiaoxia ^a   Teng, Yen Tung A ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLONY STIMULATING FACTOR 1; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; OSTEOCLAST DIFFERENTIATION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRAM NEGATIVE BACTERIUM; MOUSE; NONHUMAN; OSTEOLYSIS; PERIODONTITIS; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; ACTINOBACILLUS INFECTIONS; ADOLESCENT; ADULT; ALVEOLAR BONE LOSS; ANIMALS; ANTIGENS, CD4; CARRIER PROTEINS; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; PERIODONTITIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TH1 CELLS;

EID: 33746636395     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00491-06     Document Type: Article

References (38)

1. Al-Rasheed, A., H. Scheerens, D. M. Rennick, H. M. Fletcher, and D. N. Tatakis. 2003, Accelerated alveolar bone loss in mice lacking interleukin-10. J. Dent. Res. 82:632-635.
2. + T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect. Immun. 67:2804-2809.
3. Baron, C. L., G. Raposo, S. M. Scholl, H. Bausinger, D. Tenza, A. Bohbot, P. Pouillart, B. Goud, D. Hanau, and J. Salamero. 2005. Modulation of MHC class II transport and lysosome distribution by macrophage-colony stimulating factor in human dendritic cells derived from monocytes. J. Cell Sci. 114:999-1010.
4. Brown, J. M., J. Zhang, and E. T. Keller. 2004. OPG, RANKL and RANK in cancer metastasis: expression and regulation. Cancer Treat. Res. 118:149-172.
5. Canete, J. D., S. E. Martinez, J. Farres, R. Sanmarti, M. Blay, A. Gomez, G. Salvador, and J. Munoz-Gomez. 2000. Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann. Rheum. Dis. 59:263-268.
6. Choi, Y., K. M. Woo, S. H. Ko, Y. J. Lee, S. J. Park, H. M. Kim, and B. S. Kwon. 2001. Osteoclastogenesis is enhanced by activated B cells but suppressed by activated CD8(+) T cells. Eur. J. Immunol. 31:2179-2188.
7. Ellis, T. N., and B. L. Beaman. 2004. Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology 112:2-12.
8. Fox, S. W., and T. J. Chambers. 2000. Interferon-γ directly inhibits TRANCE-induced osteoclastogenesis. Biochem. Biophys. Res. Commun. 276:868-872.
9. Gorska, R., H. Gregorek, R. Kowalski, A. Laskus-Perendyk, M. Syczewska, and K. Madalinski. 2003. Relationship between clinical parameters and cytokine profiles in inflamed gingival tissue and serum samples from patients with chronic periodontitis. J. Clin. Periodontol. 30:1046-1052.
10. Goutoudi, P., E. Diza, and M. Arvanitidou. 2004. Effects of periodontal therapy on crevicular fluid interleukin-1β and interleukin-10 levels in chronic periodontitis. J. Dent. 32:511-520.
11. Han, S., Y. Song, Y.-H. Lee, Y.-R. Lee, C.-K. Lee, K. Cho, and K. Kim. 2005. Macrophage-colony stimulating factor enhances MHC-restricted presentation of exogenous antigen in dendritic cells. Cytokine 32:187-193.
12. Herold, K. C. 2004. Achieving antigen-specific immune regulation. J. Clin. Investig. 113:346-349.
13. Hofbauer, L. C., and M. Schoppet. 2004. Clinical implication of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. JAMA 28:490-495.
14. Honore, P., N. M. Luger, M. A. C. Sabino, M. J. Schwei, S. D. Rogers, and D. B. Mach. 2000. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord. Nat. Med. 6:521-528.
15. Kikuchi, T., C. L. Hahn, S. Tanaka, S. E. Barbour, H. A. Schenkein, and J. G. Tew. 2004. Dendritic cells stimulated with Actinobacillus actinomycetemcomitans elicit rapid gamma interferon responses by natural killer cells. Infect. Immun. 72:5089-5096.
16. Kim, N., Y. Kadono, M. Takami, J. Lee, S.-H. Lee, F. Okada, J. H. Kim, T. Kobayashi, P. R. Odgren, H. Nakano, W.-C. Yeh, S.-K. Lee, J. A. Lorenzo, and Y. Choi. 2005. Osteoclast differentiation independent of the TRANCE-RANK-TRAF6 axis. J. Exp. Med. 202:589-595.
17. Koga, T., M. Inui, K. Inoue, S. Kim, A. Suematsu, E. Kobayashi, T. Iwata, H. Ohnishi, T. Matozaki, T. Kodama, T. Taniguchi, H. Takayanagi, and T. Takai. 2004. Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis. Nature 428:758-763.
18. Kotake, S., Y. Nanke, M. Mogi, M. Kawamoto, T. Furuya, T. Yago, T. Kobashigawa, and N. Kamatani. 2005. IFN-γ-producing human T cells directly induce osteoclastogenesis from human monocytes via the expression of RANKL. Eur. J. Immunol. 35:1-11.
19. + T cells trigger RANKL-mediated enhanced alveolar bone loss in diabetic NOD mice. Diabetes 54:1477-1486.
20. Mochizuki, S., M. Kobayashi, T. Suzuki, A. Oikawa, T. Koseki, T. Nishihara, and K. Hasegawa. 2004. Gamma-interferon enhances expression of CD14/MyD88 and subsequent responsiveness to lipopolysaccharide from Actinobacillus actinomycetemcomitans in human gingival fibroblasts. J. Periodontal Res. 39:333-343.
21. Park, S. H., D. J. Min, M. L. Cho, W. U. Kim, J. Youn, W. Park, et al. 2001. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. Arthritis Rheum. 44:561-569.
22. Romas, E., M. T. Gillespie, and T. J. Martin. 2002. Involvement of receptor activator of NFκB ligand and tumor necrosis factor-α in bone destruction in rheumatoid arthritis. Bone 30:340-346.
23. Sasaki, H., Y. Okamatsu, T. Kawai, R. Kent, M. Taubman, and P. Stashenko. 2004. The interleukin-10 knockout mouse is highly susceptible to Porphyromonas gingivalis-induced alveolar bone loss. J. Periodontal Res. 39:432-441.
24. Suarez, J. J., A. M. Ocampo, R. E. Duenas, and A. Rodriguez. 2004. Relative proportions of T-cell subpopulations and cytokines that mediate and regulate the adaptive immune response in patients with aggressive periodontitis. J. Periodontol. 75:1209-1215.
25. Takayanagi, H., K. Ogasawara, S. Hida, T. Chiba, S. Murata, K. Sato, et al. 2000. T cell mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-γ. Nature 408:600-605.
26. Tanaka, S., K. Nakamura, N. Takahasi, and T. Suda. 2005. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANK-RANK signaling system. Immunol. Rev. 208:30-49.
27. Taubman, M. A., and T. Kawai. 2001. Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorption. Crit. Rev. Oral Biol. Med. 12:125-135.
28. Teng, Y.-T. A., H. Nguyen, A. Hassanloo, R. P. Ellen, H. Hozumi, and R. M. Gorczynski. 1999. Periodontal immune responses of human lymphocytes in Actinobacillus actinomycetemcomitans-inoculated NOD/SCID mice engrafted with peripheral blood leukocytes of periodontitis patients. J. Periodontal Res. 34:54-61.
29. Teng, Y.-T. A., H. Nguyen, X. Gao, Y. Y. Kong, R. M. Gorczynski, B. Singh, R. P. Ellen, and J. M. Penninger. 2000. Functional human T-cell immunity and osteoprotegerin-ligand (OPG-L) control alveolar bone destruction in periodontal infection. J. Clin. Investig. 106:R59-R67.
30. Teng, Y.-T. A. 2002. Mixed periodontal Th1-Th2 cytokine profile in Actinobacillus actinomycetemcomitans-specific osteoprotegerin ligand (or RANK-L)-mediated alveolar bone destruction in vivo. Infect. Immun. 70:5269-5273.
31. Teng, Y.-T. A. 2003. The role of acquired immunity and periodontal disease progression. Crit. Rev. Oral Biol. Med. 14:237-252.
32. +-T-cell-mediated alveolar bone destruction in vivo. Infect. Immun. 73:3453-3461.
33. Teng, Y.-T. A. 2006. Protective and destructive immunity in the periodontium. 1. Innate and humoral immunity and the periodontium. J. Dent. Res. 85:198-208.
34. Teng, Y.-T. A. 2006. Protective and destructive immunity in the periodontium. 2. T-cell-mediated immunity in the periodontium. J. Dent. Res. 85:209-219.
35. Theill, L. E., W. J. Boyle, and J. M. Penninger. 2002. RANK-L and RANK: T cell, bone loss and mammalian evolution. Annu. Rev. Immunol. 20:795-823.
36. Walsh, M. C., N. Kim, Y. Kadono, J. Rho, S. Y. Lee, J. Lorenzo, and Y. Choi. 2006. Osteoimmunology: interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 24:1-31.
37. Wei, S., M. W. Wang, S. L. Teitelbaum, and F. P. Ross. 2002. Interleukin-4 reversibly inhibits osteoclastogenesis via inhibition of NF-kappa B and mitogen-activated protein kinase signaling. J. Biol. Chem. 277:6622-6630.
38. Wyzga, N., S. Varghese, S. Wikel, E. Canalis, and F. A. Sylvester. 2004. Effects of activated T cells on osteoclastogenesis depend on how they are activated. Bone 35:614-620.